Centene (CNC) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Centene (CNC) quarterly earnings & revenue
Centene (CNC) reported revenue of $49.94B for Q1 2026, up 7.1% year-over-year, with net income of $1.54B and diluted EPS of $3.11.
Over the last four reported quarters, Centene generated $198.10B in revenue and $-6.44B in net income.
Centene's next earnings report is scheduled for July 28, 2026 before market open; analysts estimate EPS of $1.05.
Centene quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $49.94B | +7.1% | $1.54B | $3.11 |
| Q4 2025 | $49.73B | +21.9% | $-1.10B | $-2.24 |
| Q3 2025 | $49.69B | +18.2% | $-6.63B | $-13.50 |
| Q2 2025 | $48.74B | +22.4% | $-253.00M | $-0.51 |
| Q1 2025 | $46.62B | +15.4% | $1.31B | $2.63 |
| Q4 2024 | $40.80B | +3.4% | $283.00M | $0.56 |
| Q3 2024 | $42.02B | +10.5% | $713.00M | $1.36 |
| Q2 2024 | $39.84B | +5.9% | $1.15B | $2.16 |
Centene (CNC) — frequently asked questions
When does Centene (CNC) report earnings next?
Centene is expected to report earnings on July 28, 2026 before market open. Analysts estimate EPS of $1.05.
What was CNC's revenue last quarter?
Centene reported revenue of $49.94B in Q1 2026, up 7.1% from the same quarter a year earlier.
What was CNC's EPS last quarter?
Centene reported diluted EPS of $3.11 in Q1 2026.
Is Centene profitable?
Centene is currently not profitable, with $-6.44B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)